221 related articles for article (PubMed ID: 15772293)
1. Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
Chen J; Kuei C; Sutton S; Wilson S; Yu J; Kamme F; Mazur C; Lovenberg T; Liu C
Mol Pharmacol; 2005 Jun; 67(6):2070-6. PubMed ID: 15772293
[TBL] [Abstract][Full Text] [Related]
2. PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor.
Lattanzi R; Maftei D; Negri L; Fusco I; Miele R
Neuropeptides; 2018 Oct; 71():32-42. PubMed ID: 30253862
[TBL] [Abstract][Full Text] [Related]
3. Cloning and developmental expression analysis of prokineticin 2 and its receptor PKR2 in the Syrian hamster surpachiasmatic nucleus.
Ji Y; Li X
Brain Res; 2009 May; 1271():18-26. PubMed ID: 19327346
[TBL] [Abstract][Full Text] [Related]
4. Bv8/Prokineticins and their Receptors A New Pronociceptive System.
Negri L; Lattanzi R; Giannini E; Canestrelli M; Nicotra A; Melchiorri P
Int Rev Neurobiol; 2009; 85():145-57. PubMed ID: 19607967
[TBL] [Abstract][Full Text] [Related]
5. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
Boulberdaa M; Urayama K; Nebigil CG
Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
[TBL] [Abstract][Full Text] [Related]
6. Distinct localization of prokineticin 2 and prokineticin receptor 2 mRNAs in the rat suprachiasmatic nucleus.
Masumoto KH; Nagano M; Takashima N; Hayasaka N; Hiyama H; Matsumoto S; Inouye ST; Shigeyoshi Y
Eur J Neurosci; 2006 Jun; 23(11):2959-70. PubMed ID: 16819985
[TBL] [Abstract][Full Text] [Related]
7. Mitogenic functions of endocrine gland-derived vascular endothelial growth factor and Bombina variegata 8 on steroidogenic adrenocortical cells.
Keramidas M; Faudot C; Cibiel A; Feige JJ; Thomas M
J Endocrinol; 2008 Mar; 196(3):473-82. PubMed ID: 18310443
[TBL] [Abstract][Full Text] [Related]
8. Activation of amygdala prokineticin receptor 2 neurons drives the anorexigenic activity of the neuropeptide PK2.
Yin TC; Mittal A; Buscaglia P; Li W; Sebag JA
J Biol Chem; 2023 Jan; 299(1):102814. PubMed ID: 36539034
[TBL] [Abstract][Full Text] [Related]
9. Bv8/Prokineticin proteins and their receptors.
Negri L; Lattanzi R; Giannini E; Melchiorri P
Life Sci; 2007 Sep; 81(14):1103-16. PubMed ID: 17881008
[TBL] [Abstract][Full Text] [Related]
10. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors.
Masuda Y; Takatsu Y; Terao Y; Kumano S; Ishibashi Y; Suenaga M; Abe M; Fukusumi S; Watanabe T; Shintani Y; Yamada T; Hinuma S; Inatomi N; Ohtaki T; Onda H; Fujino M
Biochem Biophys Res Commun; 2002 Apr; 293(1):396-402. PubMed ID: 12054613
[TBL] [Abstract][Full Text] [Related]
11. Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
Negri L; Lattanzi R
Curr Opin Pharmacol; 2012 Feb; 12(1):62-6. PubMed ID: 22136937
[TBL] [Abstract][Full Text] [Related]
12. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.
Pasquali D; Rossi V; Staibano S; De Rosa G; Chieffi P; Prezioso D; Mirone V; Mascolo M; Tramontano D; Bellastella A; Sinisi AA
Endocrinology; 2006 Sep; 147(9):4245-51. PubMed ID: 16763065
[TBL] [Abstract][Full Text] [Related]
13. The balance of concentration between Prokineticin 2β and Prokineticin 2 modulates the food intake by STAT3 signaling.
Maftei D; Lattanzi R; Vincenzi M; Squillace S; Fullone MR; Miele R
BBA Adv; 2021; 1():100028. PubMed ID: 37082024
[TBL] [Abstract][Full Text] [Related]
14. Prokineticin receptors in cardiovascular function: foe or friend?
Nebigil CG
Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
[TBL] [Abstract][Full Text] [Related]
15. Changes in the responsiveness of hypothalamic PK2 and PKR1 gene expression to fasting in developing male rats.
Iwasa T; Matsuzaki T; Tungalagsuvd A; Munkhzaya M; Kawami T; Yamasaki M; Murakami M; Kato T; Kuwahara A; Yasui T; Irahara M
Int J Dev Neurosci; 2014 Nov; 38():87-90. PubMed ID: 25153663
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of the prokineticins (endocrine gland-derived vascular endothelial growth factor and Bv8) and their receptors in the human endometrium across the menstrual cycle.
Battersby S; Critchley HO; Morgan K; Millar RP; Jabbour HN
J Clin Endocrinol Metab; 2004 May; 89(5):2463-9. PubMed ID: 15126578
[TBL] [Abstract][Full Text] [Related]
17. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
18. Bv8-prokineticins and their receptors: modulators of pain.
Negri L; Lattanzi R
Curr Pharm Biotechnol; 2011 Oct; 12(10):1720-7. PubMed ID: 21466441
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms that underlie the internalization and extracellular signal regulated kinase 1/2 activation by PKR2 receptor.
Yin W; Liu H; Peng Z; Chen D; Li J; Li JD
Cell Signal; 2014 May; 26(5):1118-24. PubMed ID: 24509228
[TBL] [Abstract][Full Text] [Related]
20. Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport.
Watson RP; Lilley E; Panesar M; Bhalay G; Langridge S; Tian SS; McClenaghan C; Ropenga A; Zeng F; Nash MS
Neurogastroenterol Motil; 2012 Jan; 24(1):65-75, e12. PubMed ID: 22050240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
